Literature DB >> 29387910

Bone density and microarchitecture in hepatitis C and HIV-coinfected postmenopausal minority women.

M T Yin1, A RoyChoudhury2, K Nishiyama3, T Lang4, J Shah3, S Olender3, D C Ferris5, C Zeana5, A Sharma6, B Zingman6, M Bucovsky3, I Colon3, E Shane3.   

Abstract

We found that HIV+/HCV+ women had 7-8% lower areal bone mineral density (aBMD) by dual-energy x-ray absorptiometry (DXA) at the spine, hip, and radius (p < 0.01) and 5-7% lower volumetric BMD (vBMD) by central quantitative computed tomography (cQCT) at the spine and hip (p < 0.05). These data suggest that true deficits in vBMD may contribute to bone fragility and excess fractures reported in HIV+/HCV+ women.
INTRODUCTION: aBMD by DXA is lower in persons coinfected with HIV and HCV (HIV+/HCV+) than with HIV monoinfection (HIV+). However, weight is often also lower with HCV infection, and measurement of aBMD by DXA can be confounded by adiposity; we aimed to determine whether true vBMD is also lower in HIV+/HCV+ coinfection.
METHODS: We measured aBMD of the lumbar spine (LS), total hip (TH), femoral neck (FN), and ultradistal radius (UDR) by DXA and vBMD of the spine and hip by cQCT and of the distal radius and tibia by high-resolution peripheral QCT (HRpQCT) in 37 HIV+/HCV+ and 119 HIV+ postmenopausal women. Groups were compared using Student's t tests with covariate adjustment by multiple regression analysis.
RESULTS: HIV+/HCV+ and HIV+ women were of similar age and race/ethnicity. HIV+/HCV+ women had lower body mass index (BMI) and trunk fat and were more likely to smoke and less likely to have a history of AIDS. In HIV+/HCV+ women, aBMD by DXA was 7-8% lower at the LS, TH, and UDR (p < 0.01). Similarly, vBMD by cQCT was 5-7% lower at the LS and TH (p < 0.05). Between-group differences in LS aBMD and vBMD remained significant after adjustment for BMI, smoking, and AIDS history. Tibial total vBMD by HRpQCT was 10% lower in HIV+/HCV+ women.
CONCLUSION: HIV+/HCV+ postmenopausal women had significantly lower spine aBMD and vBMD. These deficits in vBMD may contribute to bone fragility and excess fractures reported in HIV+/HCV+ women.

Entities:  

Keywords:  Bone density; HIV infection; Hepatitis C infection; Quantitative CT

Mesh:

Year:  2018        PMID: 29387910     DOI: 10.1007/s00198-017-4354-z

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  34 in total

1.  Bone mineral density and bone turnover in non-cirrhotic patients with chronic hepatitis C and sustained virological response to antiviral therapy with peginterferon-alfa and ribavirin.

Authors:  E Redondo-Cerezo; F Casado-Caballero; J L Martin-Rodriguez; J Hernandez-Quero; F Escobar-Jimenez; J L Gonzalez-Calvin
Journal:  Osteoporos Int       Date:  2014-03-28       Impact factor: 4.507

2.  Activation of CD8 T cells predicts progression of HIV infection in women coinfected with hepatitis C virus.

Authors:  Andrea Kovacs; Roksana Karim; Wendy J Mack; Jiaao Xu; Zhi Chen; Eva Operskalski; Toni Frederick; Alan Landay; John Voris; La Shonda Spencer; Mary A Young; Phyllis C Tien; Michael Augenbraun; Howard D Strickler; Lena Al-Harthi
Journal:  J Infect Dis       Date:  2010-03-15       Impact factor: 5.226

3.  Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy.

Authors:  Jürgen K Rockstroh; Amanda Mocroft; Vincent Soriano; Cristina Tural; Marcello H Losso; Andrzej Horban; Ole Kirk; Andrew Phillips; Bruno Ledergerber; Jens Lundgren
Journal:  J Infect Dis       Date:  2005-08-11       Impact factor: 5.226

4.  Viral hepatitis is associated with reduced bone mineral density in HIV-infected women but not men.

Authors:  Vincent Lo Re; Giovanni Guaraldi; Mary B Leonard; Anthony R Localio; Jennifer Lin; Gabriella Orlando; Lucia Zirilli; Vincenzo Rochira; Jay R Kostman; Pablo Tebas
Journal:  AIDS       Date:  2009-10-23       Impact factor: 4.177

5.  Virus clearance reduces bone fracture in postmenopausal women with osteoporosis and chronic liver disease caused by hepatitis C virus.

Authors:  Yasuji Arase; Fumitaka Suzuki; Yoshiyuki Suzuki; Norio Akuta; Masahiro Kobayashi; Hitomi Sezaki; Tetsuya Hosaka; Yusuke Kawamura; Hiromi Yatsuji; Miharu Hirakawa; Kenji Ikeda; Shiun Dong Hsieh; Yuki Oomoto; Kazuhisa Amakawa; Hisahito Kato; Tamae Kazawa; Hiroshi Tsuji; Tetsuro Kobayashi; Hiromitsu Kumada
Journal:  J Med Virol       Date:  2010-03       Impact factor: 2.327

6.  Low bone mass and high bone turnover in postmenopausal human immunodeficiency virus-infected women.

Authors:  Michael T Yin; Don J McMahon; David C Ferris; Chiyuan A Zhang; Aimee Shu; Ronald Staron; Ivelisse Colon; Jeffrey Laurence; Jay F Dobkin; Scott M Hammer; Elizabeth Shane
Journal:  J Clin Endocrinol Metab       Date:  2009-12-04       Impact factor: 5.958

7.  CD8(+) T cell activation in women coinfected with human immunodeficiency virus type 1 and hepatitis C virus.

Authors:  Andrea Kovacs; Lena Al-Harthi; Shawna Christensen; Wendy Mack; Mardge Cohen; Alan Landay
Journal:  J Infect Dis       Date:  2008-05-15       Impact factor: 5.226

Review 8.  Diagnosis of osteoporosis and assessment of fracture risk.

Authors:  John A Kanis
Journal:  Lancet       Date:  2002-06-01       Impact factor: 79.321

9.  Effect of fat on measurement of bone mineral density.

Authors:  F Javed; W Yu; J Thornton; E Colt
Journal:  Int J Body Compos Res       Date:  2009-07-01

10.  Abnormal microarchitecture and reduced stiffness at the radius and tibia in postmenopausal women with fractures.

Authors:  Emily M Stein; X Sherry Liu; Thomas L Nickolas; Adi Cohen; Valerie Thomas; Donald J McMahon; Chiyuan Zhang; Perry T Yin; Felicia Cosman; Jeri Nieves; X Edward Guo; Elizabeth Shane
Journal:  J Bone Miner Res       Date:  2010-06-18       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.